App-Quantinova.ai

Treatment Persistence With New Oral Anticoagulants for Non-Valvular Atrial Fibrillation: The Quebec Observational Study

Janie Coulombe - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Non-valvular atrial fibrillation

rivaroxaban

Alirocumab Dosing in a Real World Setting: Data From an Open-label Treatment Extension to the ODYSSEY Program for Patients With Heterozygous Familial Hypercholesterolemia

John R Guyton - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypercholesterolemia, Familial, 1

Alirocumab

Ethnic and Sex Differences in Ambulance Activation Among Hospitalized Patients With St-elevation Myocardial Infarction

Padma Kaul - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Clinical Outcomes With Beta-blockers in Patients With Myocardial Infarction and Coronary Artery Disease

Jack Tu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Benefit of Early Discharge Among Patients With Low-risk Pulmonary Embolism: Focus on Net Clinical Impact

Onur Baser - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Deep vein thrombosis

N/A

Association of High-Density Lipoprotein Cholesterol With Non-Fatal Cardiac and Non-Cardiac Events: A CANHEART Primary Prevention Sub-Study

Maria Koh - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

N/A

Photoplethysmography Using a Smartphone Application for Assessment of Ulnar Patency Prior to Transradial Angiography

David T Harnett - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Empagliflozin Reduces Markers of Arterial Stiffness, Vascular Resistance and Cardiac Workload in EMPA-REG OUTCOME

Lars Gullestad - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

BI-10773

Prenatal Predictors of Urgent Postnatal Balloon Atrial Septostomy in Transposition of Great Arteries

Prasad Ravi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Effectiveness of Rivaroxaban among Patients Diagnosed With Pulmonary Embolism

Onur Baser - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

Fetal Brain Volume as a Predictor of Postnatal Brain Injury in Neonates With Critical Congenital Heart Disease

Joanne Lau - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Congenital heart disease

N/A

Left Ventricular Septal Mechanics in Fetal Ebstei-s Anomaly

Lisa Howley - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tricuspid valve dysplasia

N/A

Early Tricuspid Regurgitation in Hypoplastic Left Heart Syndrome is Not Related to Right Ventricular Function or Mechanical Dyssynchrony

Nee Khoo - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

Failure to Adequately Reduce Tricuspid Valve Size in Hypoplastic Left Heart Syndrome: Tricuspid Valve Repair is an Important Mechanism of Significant Post-Operative Regurgitation

Billie-Jean Martin - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypoplastic left heart syndrome

N/A

A Paradoxical Relationship of Plasma Adiponectin to Cardiovascular Risk in Patients With Diabetes and Recent Acute Coronary Syndrome - the Alecardio Trial

Anna Nozza - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

Aleglitazar

Patients With Acute Coronary Syndromes and Heart Failure Admitted to Critical Care Units in Teaching Hospitals Have Lower Observed In-hospital Mortality and 30-day Readmission Rates

Padma Kaul - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Echocardiographic Prediction of Outcomes in Fetal Pulmonary Atresia With Intact Ventricular Septum

Bridget Zoeller - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary atresia with intact ventricular septum

N/A

Increasing Preload Permits Maintenance of Cardiac Output During Rapid Atrial Pacing in Infant Piglets but is Associated With Possible Right Heart Diastolic Impairment in Neonatal Piglets

Lisa K Hornberger - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Atrial septal defect

N/A

No Significant Difference in Yield of Obstructive Coronary Artery Disease Between an Initial Testing Strategy With Stress or Anatomical Imaging and Exercise Stress Testing in Ontario, Canada

Harindra C Wijeysundera - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Stable coronary artery disease

N/A

Differences in Utilization of Anti-Thrombotic Therapies and Invasive Cardiac Procedures for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the ACTION Registry - GWTG

Di Lu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microvascular complications of diabetes 1

Aspirin

Filters

28841 Abstracts